JNX

LBank Exchange Will List Janex (JNX) on September 21, 2023

Retrieved on: 
Wednesday, September 20, 2023
Learning, Database, Blockchain, Travel, Education, Marketing, Binance, E-commerce, Trust, Ecosystem, Environment, KYC, Cryptocurrency, JNX, JAL Express

Road Town, British Virgin Islands--(Newsfile Corp. - September 20, 2023) - LBank Exchange, a global digital asset trading platform, will list Janex (JNX) on September 21, 2023.

Key Points: 
  • Road Town, British Virgin Islands--(Newsfile Corp. - September 20, 2023) - LBank Exchange, a global digital asset trading platform, will list Janex (JNX) on September 21, 2023.
  • For all users of LBank Exchange, the JNX/USDT trading pair will be officially available for trading at 11:00 UTC on September 21, 2023.
  • The Janex platform is designed to revolutionize various industries by harnessing the power of blockchain technology.
  • With plans for a decentralized exchange, staking capabilities, and asset rewards, Janex seeks to create a dynamic and profitable ecosystem that benefits both users and businesses.

Blue Line Aviation Scraps Plans For Additional Development in Johnston County

Retrieved on: 
Thursday, March 9, 2023
Aviation, FAA, Growth, Blue Line (Calgary), Airport, Sale, Blue Line, Airline, JNX

SMITHFIELD, N.C., March 9, 2023 /PRNewswire/ -- Blue Line Aviation, North Carolina's largest flight school, has announced plans to immediately cease all investment in their previously announced expansion in Johnston County.

Key Points: 
  • Blue Line Aviation has scrapped plans to further invest in their Johnston County expansion plan, and will invest elsewhere.
  • SMITHFIELD, N.C., March 9, 2023 /PRNewswire/ -- Blue Line Aviation, North Carolina's largest flight school, has announced plans to immediately cease all investment in their previously announced expansion in Johnston County.
  • Blue Line Aviation invested significant funds to purchase, plan, annex, and rezone a 14 acre parcel.
  • For more information about Blue Line Aviation, please visit www.bluelineaviation.com

FAA Validates Complaints Against Johnston County Airport Authority

Retrieved on: 
Wednesday, February 15, 2023
Federal Aviation Administration, State, Metropolitan Washington Airports Authority, Behavior, Theft or bribery concerning programs receiving Federal funds, Complaint, FAA, Growth, Exclusive Rights, Transport, Airport Improvement Program, Blue Line, Airline, JNX, Aviation

SMITHFIELD, N.C., Feb. 15, 2023 /PRNewswire/ -- The Federal Aviation Administration's (FAA) Southern Region reviewed allegations made by Blue Line Aviation that the Johnston County Airport Authority, owner and operator of the Johnston County Airport (JNX), violated its Federal Grant Assurance obligations. Airports that are Federally Funded are subject to certain requirements to protect the investment of public dollars. The Johnston County Airport was found to be in violation of those requirements by discriminating against Blue Line Aviation.

Key Points: 
  • SMITHFIELD, N.C., Feb. 15, 2023 /PRNewswire/ -- The Federal Aviation Administration's (FAA) Southern Region reviewed allegations made by Blue Line Aviation that the Johnston County Airport Authority, owner and operator of the Johnston County Airport (JNX), violated its Federal Grant Assurance obligations.
  • The Johnston County Airport was found to be in violation of those requirements by discriminating against Blue Line Aviation.
  • In a letter to the Airport Authority dated February 6, 2023, the FAA completed the review and found that the Johnston County Airport Authority did not meet the FAA's standard of compliance with regard to Grant Assurance 22 (Economic Nondiscrimination) and Grant Assurance 23 (Exclusive Rights).
  • The Johnston County Airport Authority has been the subject of multiple lawsuits and FAA complaints related to alleged mistreatment of Blue Line Aviation and Adventist World Aviation, amongst other groups.

Blue Line Aviation Founders Create $100,000 "Fly Right" Scholarship For Students Who Soar Above and Beyond

Retrieved on: 
Tuesday, January 24, 2023
Aircraft, Aviation, Boeing, Metro Blue Line (Minnesota), Student, Economic development, Blue Line, Airport, Environment, Character, RDU, Straighten Up and Fly Right, Atmosphere, Marketing, Airline, Management, JNX

SMITHFIELD, N.C., Jan. 24, 2023 /PRNewswire/ -- Blue Line Aviation, the largest commercial pilot training school in the state of North Carolina announces the Fly Right Scholarship program. The $100,000 flight training scholarship will be awarded this school year to a Johnston County Public School graduate who soars above and beyond to do what's right, who has a high level of personal ethics and character, and who positively contributes to their world around them, as nominated by their teachers and peers and approved by an impartial panel.

Key Points: 
  • Blue Line Aviation announces the $100,000 Fly Right Scholarship to be given to a local public school graduate.
  • SMITHFIELD, N.C., Jan. 24, 2023 /PRNewswire/ -- Blue Line Aviation, the largest commercial pilot training school in the state of North Carolina announces the Fly Right Scholarship program.
  • Blue Line Aviation President, Adam Walters says "Blue Line Aviation is committed to doing what is right, all the time, no matter what.
  • For more information about Blue Line Aviation or the Fly Right Scholarship program, please visit www.bluelineaviation.com

Therma Bright Invests in the Development of Novel Treatments for COVID-19, Asthma, and Chronic Obstructive Pulmonary Disease (COPD)

Retrieved on: 
Thursday, December 1, 2022
COVID-19, Medical school, ROAD, University, Cell, University of California, Davis, Pneumonia, Pain, Chronic lung disease, COPD, Degenerative disease, Acquisition, Patient, Pulmonology, Itch, Chronic obstructive pulmonary disease, FSE, Interstitial lung disease, Cell proliferation, JNX, Research, FDA, Inflammation, Drug development, UCD, COVID, Asthma, School, Therapy, UCAN, UC, Infarction, Stroke, Critical Care Medicine (journal), Acute respiratory distress syndrome, Office for National Statistics, Pharmaceutical industry, Medicine, Therma

Statins have been used clinically to treat high cholesterol levels which protect patients from heart attacks and strokes for over 35 years.

Key Points: 
  • Statins have been used clinically to treat high cholesterol levels which protect patients from heart attacks and strokes for over 35 years.
  • When delivered via the inhaled route, the statins are targeted to the site of disease activity for greater therapeutic benefit.
  • As well, we look forward to the promise that these statin treatments provide for chronic lung diseases including asthma and COPD."
  • Therma Bright Inc. trades on the TSXV (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX).

Training and recovery reach superhuman levels with the release of the latest in electrolyte recovery drinks, The Jinx! Hydra BCAA+

Retrieved on: 
Wednesday, May 25, 2022
Multimedia, Sport, BCAA, Motivation, Industry, Jinx, International, Ripper, JNX, Instagram, Immunity, Shadow, Beer, Online shopping, Facebook

Training and recovery reach superhuman levels with the release of The Jinx!

Key Points: 
  • Training and recovery reach superhuman levels with the release of The Jinx!
  • offers an immunity boosting vitamin stack and an advanced amino matrix that packs a punch when it comes to enhanced training, faster muscle recovery and better results.
  • We see our customers pushing themselves beyond their limits every day, and our products are helping them get there.
  • A little bit dark and lot superhuman, JNX Sports disrupts the industry with innovative products, global distribution and unworldly flavours.

Therma Bright Successfully Up-lists to the OTCQB Venture Market Under Symbol TBRIF

Retrieved on: 
Tuesday, September 14, 2021
Itch, CEO, FDA, OTCQB, Technology, FSE, Inflammation, Company, U.S. Securities and Exchange Commission, JNX, Letter, Documentation, Therma, COVID-19, Review, Pain, EUA, Compliance, US, Research, Security (finance), Pharmaceutical industry

Provides Update on FDA-EUA Application Process

Key Points: 
  • Toronto, Ontario--(Newsfile Corp. - September 14, 2021) - Therma Bright Inc. (TSXV: THRM) (OTCQB: TBRIF) ("Therma" or the "Company"), developer of its smart-enabled AcuVid COVID-19 Rapid Antigen Saliva Test and other progressive diagnostic and medical device technologies, announced today its successful up-listing from the OTC Pink Sheets to the OTCQB Venture Market (the "OTCQB").
  • Therma Bright will commence trading on the OTCQB with the market open on September 14, 2021, under the symbol "TBRIF".
  • "We're excited to be up-listed to the OTCQB, which is an important milestone for Therma Bright," shared Rob Fia, CEO of Therma Bright.
  • Therma Bright Inc. trades on the TSXV (TSXV: THRM) (OTCQB: TBRIF) (FSE: JNX).

Therma Bright Provides Update on FDA-EUA Application Process

Retrieved on: 
Wednesday, September 1, 2021
Company, FSE, Saliva, Pain, Technology, Administration, Trial of the century, CE, Research, EUA, Inflammation, Review, OTC Markets Group, Itch, Documentation, CEO, US Foods, Sale, Emergency Use Authorization, FDA, COVID-19, JNX, Pharmaceutical industry, Vaccine, Medical device

"During the past 30 days, the Therma Bright team has been actively engaged with officials at the FDA around our first-of-its-kind AcuVid COVID-19 Rapid Antigen Saliva Test and our successful clinical study results," expressed Rob Fia, CEO of Therma Bright.

Key Points: 
  • "During the past 30 days, the Therma Bright team has been actively engaged with officials at the FDA around our first-of-its-kind AcuVid COVID-19 Rapid Antigen Saliva Test and our successful clinical study results," expressed Rob Fia, CEO of Therma Bright.
  • As AcuVid is an innovative, leading-edge rapid saliva test solution, additional information was required for the FDA-EUA review process.
  • Therma Bright is not making any express or implied claims that its test product has the ability to eliminate or cure COVID-19 or the SARS-CoV-2 virus.
  • Therma Bright Inc. trades on the TSXV (TSXV: THRM) (OTC Pink: TBRIF) (FSE: JNX).

Therma Bright Enters into Securities for Services Agreement, Debt Settlement, and Issues Options

Retrieved on: 
Thursday, August 12, 2021
TSX Venture Exchange, Inflammation, OTC Markets Group, JNX, US, Company, Itch, COVID-19, Consultant, Compliance, FDA, Technology, Pain, FSE, Security (finance)

In consideration for its services, Therma Bright will issue up to 800,000 warrants, in tranches, upon certain milestones being met.

Key Points: 
  • In consideration for its services, Therma Bright will issue up to 800,000 warrants, in tranches, upon certain milestones being met.
  • All of these securities are subject to a hold period expiring December 13, 2021 in accordance with applicable securities laws and the policies of the TSXV.
  • The Company also advises that it has cancelled two securities for services consulting agreements previously announced May 6, 2021 and April 22, 2021.
  • Therma Bright also announces that it has negotiated a debt settlement with an arm's length creditor.